Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | NEJM
Clinical trial studies combination immunotherapy for colorectal cancer | Center for Cancer Research
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Cells | Free Full-Text | Immunotherapy, Inflammation and Colorectal Cancer
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect
Rectal Cancer Disappears After Experimental Use of Immunotherapy | Memorial Sloan Kettering Cancer Center
View of The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation | Annals of Gastroenterology
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal 'Immunoablative' Neoadjuvant Immunotherapy Clinical Trial | Memorial Sloan Kettering Cancer Center
Patients with MSI-High Colorectal Cancer Sought for Immunotherapy Trial – Consult QD
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy
Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy - ScienceDirect
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Precision oncology in metastatic colorectal cancer — from biology to medicine | Nature Reviews Clinical Oncology
Key immunotherapy trials in metastatic colorectal cancer (CRC). | Download Table
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
Frontiers | Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Advances in immunotherapy for colorectal cancer: a review | Semantic Scholar
